Analysis of chromosomal aberrations, sister-chromatid exchanges and micronuclei in peripheral lymphocytes of pharmacists before and after working with cytostatic drugs.
The frequencies of chromosome aberrations, SCEs and micronuclei (cytokinesis-block method) in blood lymphocytes were compared among six nonsmoking female pharmacists before and after 1 year of working with cytostatic drugs. All possible precautions were taken to avoid exposure to cytostatics, including proper protective clothing and a monitored, negative-pressured working environment with vertical laminar flow cabinet. As referents, an age-matched group of six nonsmoking female hospital workers not dealing with cytostatics was simultaneously sampled twice with the same time interval. The pharmacists showed a marginally higher mean frequency of SCEs/cell (6.3; P = 0.049) after the working period than 1 year earlier (5.8). On the other hand, the referents, with no obvious exposure, had a higher mean number of cells with chromatid-type aberrations, gaps excluded, in the second sampling (2.0%; P = 0.048) than in the first one (0.5%). In addition, a slight (P = 0.055) trend towards a higher frequency of micronucleated binucleate cells was observed in the second sampling for both the exposed and control subjects. As such findings suggest technical variation in the cytogenetic parameters, the small difference observed in SCEs for the pharmacists between the two samplings was probably not related to the cytostatics exposure. No statistically significant differences were observed for any of the cytogenetic parameters in comparisons between the pharmacists and the referents. The findings suggest that caution should be exercised in comparing results obtained from two different samplings in prospective cytogenetic studies.
Roth
S
S
Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki.
Norppa
H
H
Järventaus
H
H
Kyyrönen
P
P
Ahonen
M
M
Lehtomäki
J
J
Sainio
H
H
Sorsa
M
M
D000328:Adult; D000970:Antineoplastic Agents / Q000633:toxicity*; D002467:Cell Nucleus / Q000473:pathology; D002869:Chromosome Aberrations; D003582:Cytogenetics / Q000379:methods; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000473:pathology*; D008875:Middle Aged; D016273:Occupational Exposure; D010564:Personnel, Hospital; D010595:Pharmacists
D000970:Antineoplastic Agents